REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 58 filers reported holding REDHILL BIOPHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | +50.0% | 12,054 | +189.5% | 0.00% | – |
| Q2 2022 | $4,000 | -76.5% | 4,164 | -37.3% | 0.00% | – |
| Q1 2022 | $17,000 | -29.2% | 6,642 | -26.5% | 0.00% | – |
| Q4 2021 | $24,000 | -80.5% | 9,041 | -66.4% | 0.00% | -100.0% |
| Q3 2021 | $123,000 | +434.8% | 26,881 | +711.4% | 0.00% | +200.0% |
| Q2 2021 | $23,000 | +76.9% | 3,313 | +91.8% | 0.00% | – |
| Q1 2021 | $13,000 | +333.3% | 1,727 | +320.2% | 0.00% | – |
| Q4 2020 | $3,000 | – | 411 | +774.5% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 47 | -96.1% | 0.00% | -100.0% |
| Q3 2019 | $8,000 | +60.0% | 1,193 | +44.1% | 0.00% | – |
| Q2 2019 | $5,000 | -58.3% | 828 | -42.3% | 0.00% | -100.0% |
| Q1 2019 | $12,000 | – | 1,436 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2016 | $1,000 | -85.7% | 100 | -84.5% | 0.00% | -100.0% |
| Q2 2016 | $7,000 | +75.0% | 646 | +115.3% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | -75.0% | 300 | -76.1% | 0.00% | -50.0% |
| Q3 2015 | $16,000 | -57.9% | 1,253 | -52.5% | 0.00% | -60.0% |
| Q1 2015 | $38,000 | +153.3% | 2,637 | +129.7% | 0.01% | +400.0% |
| Q4 2014 | $15,000 | +200.0% | 1,148 | +225.2% | 0.00% | 0.0% |
| Q3 2014 | $5,000 | -68.8% | 353 | -61.9% | 0.00% | -50.0% |
| Q2 2014 | $16,000 | +45.5% | 927 | +16.6% | 0.00% | +100.0% |
| Q1 2014 | $11,000 | +266.7% | 795 | +171.3% | 0.00% | – |
| Q2 2013 | $3,000 | – | 293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |